BACKGROUND: Understanding methamphetamine (MAMP) and amphetamine (AMP) excretion in sweat is important for interpreting sweat and hair testing results in judicial, workplace, and drug treatment settings. METHODS: Participants (n = 8) received 4 10-mg (low) oral doses of sustained-release S-(+)-MAMP HCl (d-MAMP HCl) within 1 week in a double-blind, institutional review board-approved study. Five participants also received 4 20-mg (high) doses 3 weeks later. PharmChek sweat patches (n = 682) were worn for periods of 2 h to 1 week during and up to 3 weeks after dosing. The mass of MAMP and AMP in each patch was measured by GC-MS, with a limit of quantification of 2.5 ng/patch. RESULTS:MAMP was measurable in sweat within 2 h of dosing. After low and high doses, 92.9% and 62.5% of weekly sweat patches were positive, with a median (range) MAMP of 63.0 (16.8-175) and 307 (199-607) ng MAMP/patch, respectively; AMP values were 15.5 (6.5-40.5) and 53.8 (34.0-83.4) ng AMP/patch. Patches applied 2 weeks after the drug administration week had no measurable MAMP following the low doses, and only 1 positive result following the high doses. Using criteria proposed by the Substance Abuse Mental Health Services Administration, 85.7% (low) and 62.5% (high) weekly sweat patches from the dosing week were positive for MAMP, and all patches applied after the dosing week were negative. CONCLUSIONS: These data characterize the excretion of MAMP and AMP after controlled MAMP administration and provide a framework for interpretation of MAMP sweat test results in clinical and forensic settings.
RCT Entities:
BACKGROUND: Understanding methamphetamine (MAMP) and amphetamine (AMP) excretion in sweat is important for interpreting sweat and hair testing results in judicial, workplace, and drug treatment settings. METHODS:Participants (n = 8) received 4 10-mg (low) oral doses of sustained-release S-(+)-MAMP HCl (d-MAMP HCl) within 1 week in a double-blind, institutional review board-approved study. Five participants also received 4 20-mg (high) doses 3 weeks later. PharmChek sweat patches (n = 682) were worn for periods of 2 h to 1 week during and up to 3 weeks after dosing. The mass of MAMP and AMP in each patch was measured by GC-MS, with a limit of quantification of 2.5 ng/patch. RESULTS:MAMP was measurable in sweat within 2 h of dosing. After low and high doses, 92.9% and 62.5% of weekly sweat patches were positive, with a median (range) MAMP of 63.0 (16.8-175) and 307 (199-607) ng MAMP/patch, respectively; AMP values were 15.5 (6.5-40.5) and 53.8 (34.0-83.4) ng AMP/patch. Patches applied 2 weeks after the drug administration week had no measurable MAMP following the low doses, and only 1 positive result following the high doses. Using criteria proposed by the Substance Abuse Mental Health Services Administration, 85.7% (low) and 62.5% (high) weekly sweat patches from the dosing week were positive for MAMP, and all patches applied after the dosing week were negative. CONCLUSIONS: These data characterize the excretion of MAMP and AMP after controlled MAMP administration and provide a framework for interpretation of MAMP sweat test results in clinical and forensic settings.
Authors: Wonkyung Yang; Allan J Barnes; Mary G Ripple; David R Fowler; Edward J Cone; Eric T Moolchan; Heesun Chung; Marilyn A Huestis Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2006-02-24 Impact factor: 3.205
Authors: Sherri L Kacinko; Allan J Barnes; Eugene W Schwilke; Edward J Cone; Eric T Moolchan; Marilyn A Huestis Journal: Clin Chem Date: 2005-09-15 Impact factor: 8.327
Authors: Eugene W Schwilke; Allan J Barnes; Sherri L Kacinko; Edward J Cone; Eric T Moolchan; Marilyn A Huestis Journal: Clin Chem Date: 2006-06-01 Impact factor: 8.327
Authors: Mallory J E Loflin; Brian D Kiluk; Marilyn A Huestis; Will M Aklin; Alan J Budney; Kathleen M Carroll; Deepak Cyril D'Souza; Robert H Dworkin; Kevin M Gray; Deborah S Hasin; Dustin C Lee; Bernard Le Foll; Frances R Levin; Joshua A Lile; Barbara J Mason; Aimee L McRae-Clark; Ivan Montoya; Erica N Peters; Tatiana Ramey; Dennis C Turk; Ryan Vandrey; Roger D Weiss; Eric C Strain Journal: Drug Alcohol Depend Date: 2020-04-26 Impact factor: 4.492
Authors: Allan J Barnes; Bertrand R Brunet; Robin E Choo; Patrick Mura; Rolley E Johnson; Hendrée E Jones; Marilyn A Huestis Journal: Ther Drug Monit Date: 2010-08 Impact factor: 3.681
Authors: Bertrand R Brunet; Allan J Barnes; Robin E Choo; Patrick Mura; Hendre E E Jones; Marilyn A Huestis Journal: Ther Drug Monit Date: 2010-02 Impact factor: 3.681
Authors: Bertrand R Brunet; Allan J Barnes; Karl B Scheidweiler; Patrick Mura; Marilyn A Huestis Journal: Anal Bioanal Chem Date: 2008-07-08 Impact factor: 4.142
Authors: Allan J Barnes; Bruno S De Martinis; David A Gorelick; Robert S Goodwin; Erin A Kolbrich; Marilyn A Huestis Journal: Clin Chem Date: 2009-01-23 Impact factor: 8.327